Search results for " type 2"

showing 10 items of 761 documents

Age, homocysteine, and oxidative stress: Relation to hypertension and type 2 diabetes mellitus

2010

Abstract OBJECTIVES: Hyperhomocysteinemia and oxidative stress are independent risk factors for cardiovascular events, which occur more frequently in old age. We evaluated these parameters in relation to age and the presence of hypertension and type 2 diabetes mellitus. METHODS: Two hundred eighty-two subjects (female/male: 142/140; 141 were >65 years and 141 were <65 years; mean age 73.9 +/- 6.6 years and 52.5 +/- 8.2 years, respectively) were randomly recruited from those attending our institution. Blood pressure, anthropometric parameters, oxidative stress parameters (reactive oxygen species [ROS] and malondialdehyde [MDA]), and homocysteine levels were evaluated in participants. RESULTS…

AdultMalemedicine.medical_specialtyHyperhomocysteinemiaAgingSettore MED/09 - Medicina InternaHomocysteineMedicine (miscellaneous)Type 2 diabetesmedicine.disease_causechemistry.chemical_compoundInternal medicineDiabetes mellitusMalondialdehydeMedicineHumansHomocysteineAgedNutrition and Dieteticsbusiness.industryAge FactorsType 2 Diabetes MellitusMiddle Agedmedicine.diseaseMalondialdehydeaging homocysteine oxidative stress hypertension type 2 diabetesOxidative StressBlood pressureEndocrinologychemistryDiabetes Mellitus Type 2HypertensionFemalebusinessReactive Oxygen SpeciesOxidative stress
researchProduct

Polymorphonuclear leukocyte membrane fluidity, at baseline and after in vitro activation, in obesity with or without diabetes mellitus

2002

We studied a group of 28 obese subjects (mean age 38.2+/-13.5 years, body mass index 35.0+/-5.6 kg/m2) with insulin resistance demonstrated employing an euglycemic hyperinsulinemic clamp, subdivided into a subgroup with normal glucose tolerance (NGT) and a subgroup with type 2 diabetes mellitus (DM). We examined the polymorphonuclear leukocyte (PMN) membrane fluidity at baseline and after activation with 4-phorbol 12-myristate 13-acetate (PMA) or N-formyl-methionyl-leucylphenylalanine (fMLP). At baseline, PMN membrane fluidity was significantly decreased in both subgroups compared to normals. In obese subjects with NGT no correlation was found between this PMN determinant and the parameters…

AdultMalemedicine.medical_specialtyMembrane FluidityNeutrophilsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentGranulocyteNeutrophil ActivationBody Mass IndexEndocrinologyInsulin resistanceReference ValuesInternal medicineDiabetes mellitusDiabetes MellitusInternal MedicinemedicineMembrane fluidityHumansObesityPancreatic hormonebusiness.industryInsulinType 2 Diabetes Mellitushemic and immune systemsGeneral Medicinemedicine.diseasePathophysiologyEndocrinologymedicine.anatomical_structureDiabetes Mellitus Type 2Regression AnalysisFemalebusinessActa Diabetologica
researchProduct

Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients

2013

Abstract Aims The present study was undertaken to investigate the relationship between glyoxalase 1 (Glo1) enzyme activity and painful diabetic neuropathy (DN) in patients with diabetes mellitus. Methods Glo1 activity and biochemical markers were determined in blood samples from 108 patients with type 1 diabetes, 109 patients with type 2 diabetes, and 132 individuals without diabetes as a control. Painful and painless peripheral DN was assessed and multivariate regression analysis was used to determine independent association of Glo1 activity with occurrence of painful DN. Results In patients with type 1 and type 2 diabetes mellitus and painful DN compared to patients with painless DN, Glo1…

AdultMalemedicine.medical_specialtyMultivariate analysisEndocrinology Diabetes and MetabolismPainType 2 diabetesSeverity of Illness IndexGastroenterologyEndocrinologyDiabetic NeuropathiesInternal medicineDiabetes mellitusInternal MedicinemedicineHumansPain MeasurementGlycated HemoglobinType 1 diabetesbusiness.industryConfoundingLactoylglutathione LyasePeripheral Nervous System DiseasesType 2 Diabetes MellitusMiddle Agedmedicine.diseasePeripheralDiabetes Mellitus Type 1EndocrinologyDiabetes Mellitus Type 2Painful diabetic neuropathyDisease ProgressionFemalebusinessBiomarkersJournal of Diabetes and its Complications
researchProduct

Phosphomannosyl receptors of lysosomal enzymes of skeletal muscle in neuromuscular diseases.

1988

The phosphomannosyl receptor system is responsible for both the receptor-mediated endocytosis and the intracellular transport of lysosomal enzymes. In the present study this receptor system was examined in affected muscles of patients with various neuromuscular diseases. The total activity of beta-N-acetyl-glucosaminidase, a marker enzyme of lysosomal hydrolases, was significantly elevated in the patients with myopathies (polymyositis and muscular dystrophies) but only slightly increased in those with neurogenic muscle atrophies (amyotrophic lateral sclerosis, polyneuropathy or other neurogenic muscle disease). The increase was most prominent in the group of polymyositis. The content of pho…

AdultMalemedicine.medical_specialtyNeuromuscular diseaseAdolescentReceptors Cytoplasmic and NuclearReceptors Cell SurfaceBiologyPolymyositisReceptor IGF Type 2Internal medicineLysosomemedicineHumansAmyotrophic lateral sclerosisMuscular dystrophyReceptorAgedMusclesSkeletal muscleGeneral MedicineNeuromuscular DiseasesMiddle Agedmedicine.diseaseMuscle atrophymedicine.anatomical_structureEndocrinologyNeurologyFemaleNeurology (clinical)medicine.symptomLysosomesActa neurologica Scandinavica
researchProduct

Assessment of induced corneal hypoxia in diabetic patients

2002

Comparative Study Address correspondence and reprint requests to Dr. C. Creuzot-Garcher, Service d'Ophtalmologie, CHU, Hopital Général, 3 Rue du Faubourg Raines, BP 1519, 21033 Dijon, France. E-mail: Catherine.creuzot-garcher@chu-dijon.fr; To assess the control of corneal hydration in patients with diabetes during a contact lens-induced hypoxia. Corneal stress was induced in 15 patients with diabetes and 23 healthy patients by having them wear contact lenses for 2 hours. Pachymetries were measured and corneal parameters (percentage recovery per hour [PRPH], time for deswelling [T99%] and induced swelling [IS]) were calculated. In the mean time, tears were collected to assess the activity of…

AdultMalemedicine.medical_specialtyPathologyCell CountCorneachemistry.chemical_compoundStress PhysiologicalOphthalmologyLactate dehydrogenaseDiabetes mellitusHumansMedicineIn patient[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansHypoxiaAged[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyL-Lactate Dehydrogenasebusiness.industryCorneal EdemaEndothelium CornealMiddle AgedHypoxia (medical)Contact Lenses Hydrophilicmedicine.diseaseeye diseasesOphthalmologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2chemistry[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansTearsTearsFemaleCorneal hypoxiasense organsmedicine.symptomSwellingbusinessAnaerobic exercise[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Reduction of HbA1c levels following nonsurgical treatment of periodontal disease in type 2 diabetics

2009

Objectives: A study was made of the effect of nonsurgical periodontal treatment upon blood glucose control in type 2 diabetics with periodontal disease. Study design: A pre-post repeated measures analytical design was used, with a PubMed search of the related articles published up until December 2008. Results: The improvement in glycosylated hemoglobin (HbA1c) after nonsurgical periodontal treatment on comparing the baseline (8.0290±1.5539) and final values (7.7806±1.5636) was 0.2483±0.1171, and proved statistically significant (p=0.042). Conclusions: A decrease in HbA1c was observed after treatment, thus indicating improved blood glucose control in type 2 diabetics with periodontal disease.

AdultMalemedicine.medical_specialtyPeriodontal treatmentGlucose controlDentistryHba1c levelPeriodontal diseaseInternal medicinemedicineHumansGeneral DentistryPeriodontal DiseasesAgedAged 80 and overGlycated Hemoglobinbusiness.industryRepeated measures designMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Nonsurgical treatmentDiabetes Mellitus Type 2OtorhinolaryngologyUNESCO::CIENCIAS MÉDICASFemaleSurgeryHemoglobinbusinessAfter treatment
researchProduct

Effects of a home-based rehabilitation program in obese type 2 diabetics.

2012

International audience; OBJECTIVE: To assess, in obese type 2 diabetics (T2D), the impact of a home-based effort training program and the barriers to physical activity (PA) practice. METHOD: Twenty-three obese T2D patients (52.7 ± 8.2 years, BMI = 38.5 ± 7.6 kg/m(2)) were randomized to either a control group (CG), or an intervention group (IG) performing home-based cyclergometer training during 3 months, 30 min/day, with a monthly-supervised session. The initial and final measurements included: maximal graded effort test on cyclergometer, 6-minute walk test (6MWT) and 200-meter fast walk test (200mFWT), quadriceps maximal isometric strength, blood tests and quality of life assessment (SF- 3…

AdultMalemedicine.medical_specialtyQuadriceps strength030209 endocrinology & metabolismIsometric exerciseType 2 diabetes03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationQuality of lifeHumansMedicineOrthopedics and Sports MedicineMuscle StrengthObesityProspective Studies030212 general & internal medicineProspective cohort studyExerciseAgedbusiness.industry[SCCO.NEUR]Cognitive science/NeuroscienceRehabilitationMiddle Agedmedicine.disease3. Good healthTest (assessment)Diabetes Mellitus Type 2Home based rehabilitation[ SCCO.NEUR ] Cognitive science/NeuroscienceExercise TestPhysical therapyFemaleTraining programbusiness
researchProduct

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

2020

Digital

AdultMalemedicine.medical_specialtyRecombinant Fusion ProteinsGlucagon-Like Peptides030209 endocrinology & metabolismType 2 diabetesPlacebolaw.invention03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawInternal medicinemedicineHumansHypoglycemic AgentsCognitive DysfunctionRisk factorAgedbusiness.industryHazard ratioMontreal Cognitive AssessmentMiddle Agedmedicine.diseaseImmunoglobulin Fc FragmentsTreatment OutcomeDiabetes Mellitus Type 2Digit symbol substitution testFemaleDulaglutideNeurology (clinical)business030217 neurology & neurosurgerymedicine.drug
researchProduct

Diabetic foot syndrome as a possible cardiovascular marker in diabetic patients

2015

Diabetic foot ulcerations have been extensively reported as vascular complications of diabetes mellitus associated with a high degree of morbidity and mortality; in fact, some authors showed a higher prevalence of major, previous and new-onset, cardiovascular, and cerebrovascular events in diabetic patients with foot ulcers than in those without these complications. This is consistent with the fact that in diabetes there is a complex interplay of several variables with inflammatory metabolic disorders and their effect on the cardiovascular system that could explain previous reports of high morbidity and mortality rates in diabetic patients with amputations. Involvement of inflammatory marke…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismInflammationType 2 diabetesReview ArticleCardiovascular Systemlcsh:Diseases of the endocrine glands. Clinical endocrinologyEndocrinologyRisk FactorsDiabetes mellitusInternal medicinemedicineAlbuminuriaAnimalsHumansAgedDyslipidemiasInflammationlcsh:RC648-665Adiponectinbusiness.industryInterleukin-6Mortality rateMiddle Agedmedicine.diseaseDiabetic footDiabetic FootEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesImmune SystemHypertensionAlbuminuriaResistinFemalemedicine.symptombusinessdiabetic foot inflammation marker
researchProduct

Thrombin-antithrombin III complexes in type II diabetes mellitus.

1992

Several studies suggest that diabetes is associated with a hypercoagulable state. Therefore determination of thrombin-antithrombin complex (TAT) could represent a sensitive parameter for specific detection of a latent activation of the clotting system. The present study documents increased plasma TAT in a heterogeneous group of non-insulin-dependent diabetic patients. The finding of increased TAT levels both in diabetic patients with vascular complications and in vascular disease patients without diabetes suggests a relationship between existing vascular disease and the hemostatic mechanism that produces augmented thrombin activity. In acute vascular occlusions the presence of diabetes seem…

AdultMalemedicine.medical_specialtySpecific detectionEndocrinology Diabetes and MetabolismAntithrombin IIIType ii diabetesEndocrinologyReference ValuesDiabetes mellitusInternal medicineInternal MedicinemedicineHumansAgedAged 80 and overHeterogeneous groupVascular diseasebusiness.industryThrombin/Antithrombin IIIAge FactorsThrombinMiddle Agedmedicine.diseaseCerebrovascular DisordersCoagulative necrosisEndocrinologyDiabetes Mellitus Type 2Thrombin activityRegression AnalysisFemalebusinessDiabetic AngiopathiesJournal of diabetes and its complications
researchProduct